Skip to main content

Keson-Brookes Maiken

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Keson-Brookes Maiken as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

MURA Mural Oncology plc

Chief Legal Officer5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 23, 2025 (view filing)Jul 221 dayKeson-Brookes MaikenSee RemarksSSale−2.57K$2.48−$6.38K−3.6%68.8K after10b5-1
Jul 22, 2025 (view filing)Jul 184 daysKeson-Brookes MaikenSee RemarksSSale−2.16K$2.48−$5.35K−2.9%71.4K after10b5-1
Mar 5, 2025 (view filing)Mar 4-51 dayKeson-Brookes MaikenSee RemarksSSale−2.73K$3.41−$9.31K−3.6%73.6K after2 lots10b5-1
Dec 26, 2024 (view filing)Dec 233 daysKeson-Brookes MaikenSee RemarksSSale−2.56K$3.27−$8.35K−5.8%41.3K after10b5-1
Jul 18, 2024 (view filing)Jul 18Same dayKeson-Brookes MaikenSee RemarksSSale−2.16K$3.41−$7.36K−4.7%43.9K after10b5-1

RUBY Rubius Therapeutics, Inc.

CLO & Corp. Secretary1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 1, 2022 (view filing)Feb 1Same dayKeson-Brookes MaikenCLO & Corp. SecretarySSale−2.73K$6.57−$17.9K−33.8%5.34K after